{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T21:40:49Z","timestamp":1788039649696,"version":"build-2784847793"},"reference-count":155,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Gastric cancer (GC), one of the most common malignancies worldwide, is strongly linked to metastasis, significantly worsening prognosis and survival rates. Metastasis initiation relies on epithelial cells undergoing an epithelial\u2013mesenchymal transition and on an abnormal, leaky vasculature. Although the tumor cells involved in the metastatic process have a progression-associated gene signature associated with extracellular matrix organization and the epithelial-to-mesenchymal transition, they must originate from an immune-evasive ecosystem that allows tumors to hinder or evade immune surveillance, either by secreting immunosuppressive chemicals, recruiting regulatory immune cells, or expressing negative stimulatory immune checkpoint molecules such as PD-L1. Although the mechanism underlying the so-called \u201cmetastatic cascade\u201d is beginning to emerge, the tumor microenvironment, or niche, in which metastatic cells arise, remains unknown. In this review, we speculate that the epithelial\u2013mesenchymal transition generates PD-L1-expressing cancer stem cells within the primary tumor, which can form tumor niches that serve as sources of metastatic cells within the gastric adenocarcinoma microenvironment. Understanding the regulatory pathways governing metastasis may offer new avenues for developing more effective therapeutic approaches.<\/jats:p>","DOI":"10.3390\/ijms27041829","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T10:14:32Z","timestamp":1771236872000},"page":"1829","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Do Metastatic Cells Arise from PD-L1+ Cell Niches in Gastric Adenocarcinoma?"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6648-582X","authenticated-orcid":false,"given":"Erika P.","family":"Rend\u00f3n-Huerta","sequence":"first","affiliation":[{"name":"Laboratorio de Inmunobiolog\u00eda, Departamento de. Biolog\u00eda Celular y Tisular, Facultad de Medicina, UNAM, Ciudad de M\u00e9xico 04510, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0128-4939","authenticated-orcid":false,"given":"Ricardo","family":"Mel\u00e9ndez-Rend\u00f3n","sequence":"additional","affiliation":[{"name":"Laboratorio de Inmunobiolog\u00eda, Departamento de. Biolog\u00eda Celular y Tisular, Facultad de Medicina, UNAM, Ciudad de M\u00e9xico 04510, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"At-Sat","family":"Aguilar","sequence":"additional","affiliation":[{"name":"Laboratorio de Inmunobiolog\u00eda, Departamento de. Biolog\u00eda Celular y Tisular, Facultad de Medicina, UNAM, Ciudad de M\u00e9xico 04510, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis F.","family":"Montano","sequence":"additional","affiliation":[{"name":"Laboratorio de Inmunobiolog\u00eda, Departamento de. Biolog\u00eda Celular y Tisular, Facultad de Medicina, UNAM, Ciudad de M\u00e9xico 04510, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nat. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Liu, Y., Li, C., Lu, Y., Liu, C., and Yang, W. (2022). Tumor microenvironment-mediated immune tolerance in development and treatment of gastric cancer. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1016817"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s13046-024-03074-z","article-title":"Soluble immune checkpoints: Implications for cancer prognosis and response to immune checkpoint therapy and conventional therapies","volume":"43","author":"Pitts","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1158\/0008-5472.CAN-10-2217","article-title":"B7-H1 overexpression regulates epithelial-mesenchymal transition and accelerates carcinogenesis in skin","volume":"71","author":"Cao","year":"2011","journal-title":"Cancer Res."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Antonangeli, F., Natalini, A., Garassino, M.C., Sica, A., Santoni, A., and Di Rosa, F. (2020). Regulation of PD-L1 Expression by NF-kappaB in Cancer. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.584626"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.3748\/wjg.v20.i18.5403","article-title":"Role of epithelial-mesenchymal transition in gastric cancer initiation and progression","volume":"20","author":"Peng","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nrc.2017.118","article-title":"EMT in cancer","volume":"18","author":"Brabletz","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bbcan.2017.06.006","article-title":"EMT transcription factors in cancer development re-evaluated: Beyond EMT and MET","volume":"1868","author":"Goossens","year":"2017","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1084\/jem.20051725","article-title":"Twist mediates suppression of inflammation by type I IFNs and Axl","volume":"203","author":"Sharif","year":"2006","journal-title":"J. Exp. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000447238","article-title":"Therapeutic Targeting of Epithelial Plasticity Programs: Focus on the Epithelial-Mesenchymal Transition","volume":"203","author":"Malek","year":"2017","journal-title":"Cells Tissues Organs"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/1878-0261.12093","article-title":"New insights into the role of EMT in tumor immune escape","volume":"11","author":"Terry","year":"2017","journal-title":"Mol. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.canlet.2019.10.013","article-title":"Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion","volume":"468","author":"Jiang","year":"2020","journal-title":"Cancer Lett."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Choi, D.H., Shin, J.E., Lee, E., Kim, S.T., and Lim, S.H. (2025). Efficacy of First-Line Nivolumab Plus Chemotherapy in Advanced Gastric Cancer Stratified by PD-L1 Expression: A Real-World Comparison. Cancers, 17.","DOI":"10.3390\/cancers17223716"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10585-023-10217-7","article-title":"Effect of liver metastasis on the efficacy of immune checkpoint inhibitors in cancer patients: A systemic review and meta-analysis","volume":"40","author":"Tian","year":"2023","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41577-023-00970-x","article-title":"Therapeutic induction of antigen-specific immune tolerance","volume":"24","author":"Kenison","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/ni1076","article-title":"Receptor editing is the main mechanism of B cell tolerance toward membrane antigens","volume":"5","author":"Halverson","year":"2004","journal-title":"Nat. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nri3405","article-title":"Molecular mechanisms of T cell co-stimulation and co-inhibition","volume":"13","author":"Chen","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"108748","DOI":"10.1016\/j.celrep.2021.108748","article-title":"Dynamic adoption of anergy by antigen-exhausted CD4(+) T cells","volume":"34","author":"Trefzer","year":"2021","journal-title":"Cell Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nri.2017.108","article-title":"The diverse functions of the PD1 inhibitory pathway","volume":"18","author":"Sharpe","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1126\/science.adg6425","article-title":"Spatiotemporal regulation of peripheral T cell tolerance","volume":"380","author":"Brown","year":"2023","journal-title":"Science"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.it.2020.12.001","article-title":"Monocyte Regulation in Homeostasis and Malignancy","volume":"42","author":"Robinson","year":"2021","journal-title":"Trends Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1038\/s41388-018-0178-3","article-title":"miR-21 depletion in macrophages promotes tumoricidal polarization and enhances PD-1 immunotherapy","volume":"37","author":"Xi","year":"2018","journal-title":"Oncogene"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1158\/2159-8290.CD-15-1347","article-title":"TGFbeta1-Mediated SMAD3 Enhances PD-1 Expression on Antigen-Specific T Cells in Cancer","volume":"6","author":"Park","year":"2016","journal-title":"Cancer Discov."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: New Dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Baker, K.J., Houston, A., and Brint, E. (2019). IL-1 Family Members in Cancer; Two Sides to Every Story. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.01197"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e002899","DOI":"10.1136\/jitc-2021-002899","article-title":"Deregulation of HLA-I in cancer and its central importance for immunotherapy","volume":"9","author":"Hazini","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.ccell.2024.09.010","article-title":"The hallmarks of cancer immune evasion","volume":"42","author":"Galassi","year":"2024","journal-title":"Cancer Cell"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Sun, N., Tian, Y., Chen, Y., Guo, W., and Li, C. (2022). Metabolic rewiring directs melanoma immunology. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.909580"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"17789","DOI":"10.1038\/s41598-021-97292-6","article-title":"Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma","volume":"11","author":"Takahashi","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.celrep.2017.04.031","article-title":"Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression","volume":"19","author":"Shin","year":"2017","journal-title":"Cell Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1126\/science.aac9935","article-title":"MYC regulates the antitumor immune response through CD47 and PD-L1","volume":"352","author":"Casey","year":"2016","journal-title":"Science"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e1512942","DOI":"10.1080\/2162402X.2018.1512942","article-title":"HER2 signaling regulates the tumor immune microenvironment and trastuzumab efficacy","volume":"8","author":"Triulzi","year":"2019","journal-title":"Oncoimmunology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1016\/j.immuni.2023.09.004","article-title":"Cancer cell-intrinsic mechanisms driving acquired immune tolerance","volume":"56","author":"Ghorani","year":"2023","journal-title":"Immunity"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1002\/cam4.2474","article-title":"Are 90% of deaths from cancer caused by metastases?","volume":"8","author":"Dillekas","year":"2019","journal-title":"Cancer Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","article-title":"Tumor metastasis: Molecular insights and evolving paradigms","volume":"147","author":"Valastyan","year":"2011","journal-title":"Cell"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ccell.2016.09.011","article-title":"Characteristics and Significance of the Pre-metastatic Niche","volume":"30","author":"Liu","year":"2016","journal-title":"Cancer Cell"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","article-title":"Emerging Biological Principles of Metastasis","volume":"168","author":"Lambert","year":"2017","journal-title":"Cell"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11515-018-1513-3","article-title":"Metastatic tumor cells\u2014Genotypes and phenotypes","volume":"13","author":"Gao","year":"2018","journal-title":"Front. Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1158\/2159-8290.CD-17-0250","article-title":"BLIMP1 Induces Transient Metastatic Heterogeneity in Pancreatic Cancer","volume":"7","author":"Chiou","year":"2017","journal-title":"Cancer Discov."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature03799","article-title":"Genes that mediate breast cancer metastasis to lung","volume":"436","author":"Minn","year":"2005","journal-title":"Nature"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Albano, F., Russi, S., Laurino, S., Mazzone, P., Di Paola, G., Zoppoli, P., Amendola, E., Balzamo, C., Bartolo, O., and Ciuffi, M. (2024). Representing ECM composition and EMT pathways in gastric cancer using a new metastatic gene signature. Front. Cell Dev. Biol., 12.","DOI":"10.3389\/fcell.2024.1481818"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s13402-024-00932-y","article-title":"Identification of a novel gene signature related to prognosis and metastasis in gastric cancer","volume":"47","author":"Elizazu","year":"2024","journal-title":"Cell. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e010612","DOI":"10.1136\/jitc-2024-010612","article-title":"Cell-intrinsic PD-L1 signaling drives immunosuppression by myeloid-derived suppressor cells through IL-6\/Jak\/Stat3 in PD-L1-high lung cancer","volume":"13","author":"Jeong","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"ref_44","first-page":"747","article-title":"Macrophages activate mesenchymal stem cells to acquire cancer-associated fibroblast-like features resulting in gastric epithelial cell lesions and malignant transformation in vitro","volume":"17","author":"Zhang","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12943-017-0597-8","article-title":"Mesenchymal stem cells: Key players in cancer progression","volume":"16","author":"Ridge","year":"2017","journal-title":"Mol. Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e12399","DOI":"10.1111\/cpr.12399","article-title":"Enhanced gastric cancer growth potential of mesenchymal stem cells derived from gastric cancer tissues educated by CD4(+) T cells","volume":"51","author":"Xu","year":"2018","journal-title":"Cell Prolif."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1089\/scd.2018.0043","article-title":"Human Gastric Cancer Mesenchymal Stem Cell-Derived IL15 Contributes to Tumor Cell Epithelial-Mesenchymal Transition via Upregulation Tregs Ratio and PD-1 Expression in CD4(+)T Cell","volume":"27","author":"Sun","year":"2018","journal-title":"Stem Cells Dev."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"He, X., Guan, X.Y., and Li, Y. (2025). Clinical significance of the tumor microenvironment on immune tolerance in gastric cancer. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1532605"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Liao, W., Zhou, X., Lin, H., Feng, Z., Chen, X., Chen, Y., Chen, M., Lin, M., Yao, G., and Chen, J. (2025). Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1\/PD-L1 therapy. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1557461"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Hill, C.N., Maita, G., Cabrolier, C., Aros, C., Vega-Letter, A.M., Gonzalez, P., Kalergis, A.M., Luz-Crawford, P., and Owen, G.I. (2025). Galectin-9 and Tim-3 in gastric cancer: A checkpoint axis driving T cell exhaustion and Treg-mediated immunosuppression independently of anti-PD-1 blockade. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1600792"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"217152","DOI":"10.1016\/j.canlet.2024.217152","article-title":"Immune checkpoint reprogramming via sequential nucleic acid delivery strategy optimizes systemic immune responses for gastrointestinal cancer immunotherapy","volume":"599","author":"Li","year":"2024","journal-title":"Cancer Lett."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Wang, D.W., Zhang, W.H., Danil, G., Yang, K., and Hu, J.K. (2022). The role and mechanism of claudins in cancer. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.1051497"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1073\/pnas.96.1.185","article-title":"A two-step, two-signal model for the primary activation of precursor helper T cells","volume":"96","author":"Bretscher","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1067\/mai.2002.124258","article-title":"The immune tolerance network: A new paradigm for developing tolerance-inducing therapies","volume":"110","author":"Rotrosen","year":"2002","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.it.2013.10.001","article-title":"Tolerance and exhaustion: Defining mechanisms of T cell dysfunction","volume":"35","author":"Schietinger","year":"2014","journal-title":"Trends Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1470-2045(15)70054-9","article-title":"Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): A phase 2, single-arm trial","volume":"16","author":"Rizvi","year":"2015","journal-title":"Lancet Oncol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nature14011","article-title":"Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients","volume":"515","author":"Herbst","year":"2014","journal-title":"Nature"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"6822","DOI":"10.4049\/jimmunol.1003682","article-title":"Tumor cell programmed death ligand 1-mediated T cell suppression is overcome by coexpression of CD80","volume":"186","author":"Haile","year":"2011","journal-title":"J. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.oraloncology.2014.11.014","article-title":"Intrinsic and extrinsic control of expression of the immunoregulatory molecule PD-L1 in epithelial cells and squamous cell carcinoma","volume":"51","author":"Ritprajak","year":"2015","journal-title":"Oral Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e1364828","DOI":"10.1080\/2162402X.2017.1364828","article-title":"PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?","volume":"7","author":"Simon","year":"2017","journal-title":"Oncoimmunology"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1126\/science.8197455","article-title":"Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins","volume":"264","author":"Darnell","year":"1994","journal-title":"Science"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/his.13339","article-title":"CD274 (PDL1) and JAK2 genomic amplifications in pulmonary squamous-cell and adenocarcinoma patients","volume":"72","author":"Clave","year":"2018","journal-title":"Histopathology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e010130","DOI":"10.1136\/jitc-2024-010130","article-title":"Evaluation of immune checkpoint inhibitor efficacy for solid tumors with CD274 (PD-L1 gene) amplification identified by comprehensive genomic profiling: Retrospective study based on a nationwide database","volume":"12","author":"Nakayama","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nri3701","article-title":"Integrating canonical and metabolic signalling programmes in the regulation of T cell responses","volume":"14","author":"Pollizzi","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s10120-023-01405-1","article-title":"Gastric cancer mesenchymal stem cells via the CXCR2\/HK2\/PD-L1 pathway mediate immunosuppression","volume":"26","author":"Huang","year":"2023","journal-title":"Gastric Cancer"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"20852","DOI":"10.1073\/pnas.0810958105","article-title":"Oncogenic kinase NPM\/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1)","volume":"105","author":"Marzec","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1172\/JCI126022","article-title":"IL-6\/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion","volume":"129","author":"Chan","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Wang, Y.M., Liu, H.X., and Fang, N.Y. (2018). High Glucose Concentration Impairs 5-PAHSA Activity by Inhibiting AMP-Activated Protein Kinase Activation and Promoting Nuclear Factor-Kappa-B-Mediated Inflammation. Front. Pharmacol., 9.","DOI":"10.3389\/fphar.2018.01491"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1158\/1078-0432.CCR-13-2797","article-title":"Effects of MAPK and PI3K pathways on PD-L1 expression in melanoma","volume":"20","author":"Atefi","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"17810","DOI":"10.1038\/s41598-017-18132-0","article-title":"IFNgamma induces PD-L1 overexpression by JAK2\/STAT1\/IRF-1 signaling in EBV-positive gastric carcinoma","volume":"7","author":"Moon","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"21609","DOI":"10.18632\/oncotarget.15450","article-title":"The miR-25-93-106b cluster regulates tumor metastasis and immune evasion via modulation of CXCL12 and PD-L1","volume":"8","author":"Cioffi","year":"2017","journal-title":"Oncotarget"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12943-024-02176-8","article-title":"PD-1\/PD-L1 immune checkpoint blockade in breast cancer: Research insights and sensitization strategies","volume":"23","author":"Jin","year":"2024","journal-title":"Mol. Cancer"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Wang, Q., Lin, W., Tang, X., Li, S., Guo, L., Lin, Y., and Kwok, H.F. (2017). The Roles of microRNAs in Regulating the Expression of PD-1\/PD-L1 Immune Checkpoint. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18122540"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature23669","article-title":"Identification of CMTM6 and CMTM4 as PD-L1 protein regulators","volume":"549","author":"Mezzadra","year":"2017","journal-title":"Nature"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature23643","article-title":"CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity","volume":"549","author":"Burr","year":"2017","journal-title":"Nature"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"54","DOI":"10.21037\/atm.2017.11.26","article-title":"CMTM6 stabilizes PD-L1 expression and refines its prognostic value in tumors","volume":"6","author":"Mamessier","year":"2018","journal-title":"Ann. Transl. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e9536","DOI":"10.7717\/peerj.9536","article-title":"CMTM6 significantly relates to PD-L1 and predicts the prognosis of gastric cancer patients","volume":"8","author":"Li","year":"2020","journal-title":"PeerJ"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/jcb.30273","article-title":"CMTM6 and CMTM7: New leads for PD-L1 regulation in breast cancer cells undergoing EMT","volume":"123","author":"Xiao","year":"2022","journal-title":"J. Cell. Biochem."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Zhang, T., Yu, T., Yang, X., Tian, W., and Wei, J. (2022). Editorial: The mechanism and novel strategies of overcoming resistance of hematological malignancies to CAR-T cell killing. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1093339"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e1257454","DOI":"10.1080\/2162402X.2016.1257454","article-title":"PD-L1 (CD274) promoter methylation predicts survival in colorectal cancer patients","volume":"6","author":"Goltz","year":"2017","journal-title":"Oncoimmunology"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"217498","DOI":"10.1016\/j.canlet.2025.217498","article-title":"Regulation of PD-L1 glycosylation and advances in cancer immunotherapy","volume":"612","author":"Lee","year":"2025","journal-title":"Cancer Lett."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"12632","DOI":"10.1038\/ncomms12632","article-title":"Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity","volume":"7","author":"Li","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.neo.2017.02.006","article-title":"Identifying Regulatory Posttranslational Modifications of PD-L1: A Focus on Monoubiquitinaton","volume":"19","author":"Horita","year":"2017","journal-title":"Neoplasia"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cpt.2024.09.006","article-title":"Claudin-9 (CLDN9) promotes gastric cancer progression by enhancing the glycolysis pathway and facilitating PD-L1 lactylation to suppress CD8(+) T cell anti-tumor immunity","volume":"3","author":"Hu","year":"2025","journal-title":"Cancer Pathog. Ther."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12929-025-01202-1","article-title":"Post-translational modifications of immune checkpoints: Molecular mechanisms, tumor microenvironment remodeling, and therapeutic implications","volume":"33","author":"Hsieh","year":"2026","journal-title":"J. Biomed. Sci."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e48916","DOI":"10.7554\/eLife.48916","article-title":"Siglec1-expressing subcapsular sinus macrophages provide soil for melanoma lymph node metastasis","volume":"8","author":"Singh","year":"2019","journal-title":"Elife"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Pell, B., Kalizhanova, A., Tursynkozha, A., Dengi, D., Kashkynbayev, A., and Kuang, Y. (2025). Dynamic PD-L1 Regulation Shapes Tumor Immune Escape and Response to Immunotherapy. Cancers, 17.","DOI":"10.1101\/2025.10.28.685116"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12943-024-02023-w","article-title":"Regulatory mechanisms of PD-1\/PD-L1 in cancers","volume":"23","author":"Lin","year":"2024","journal-title":"Mol. Cancer"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s10735-025-10598-x","article-title":"Knockdown of circ_0000372 elevates PD-L1 level through sponging miR-488-3p to restrain cell viability, motility and immune escape in gastric cancer","volume":"56","author":"Shen","year":"2025","journal-title":"J. Mol. Histol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/CAD.0000000000001002","article-title":"Circular RNA circ_0000372 contributes to the proliferation, migration and invasion of colorectal cancer by elevating IL6 expression via sponging miR-495","volume":"32","author":"Liu","year":"2021","journal-title":"Anticancer. Drugs"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/modpathol.2016.213","article-title":"Heterogeneous expression of PD-L1 in pulmonary squamous cell carcinoma and adenocarcinoma: Implications for assessment by small biopsy","volume":"30","author":"Gniadek","year":"2017","journal-title":"Mod. Pathol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"100870","DOI":"10.1016\/j.mcpro.2024.100870","article-title":"Targeted Dynamic Phospho-Proteogenomic Analysis of Gastric Cancer Cells Suggests Host Immunity Provides Survival Benefit","volume":"23","author":"Kume","year":"2024","journal-title":"Mol. Cell. Proteom."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1073\/pnas.1918167117","article-title":"The functional activity of E-cadherin controls tumor cell metastasis at multiple steps","volume":"117","author":"Na","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","article-title":"Emt: 2016","volume":"166","author":"Nieto","year":"2016","journal-title":"Cell"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Tomecka, P., Kunachowicz, D., Gorczynska, J., Gebuza, M., Kuznicki, J., Skinderowicz, K., and Choromanska, A. (2024). Factors Determining Epithelial-Mesenchymal Transition in Cancer Progression. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25168972"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s10555-016-9648-7","article-title":"EMT, cell plasticity and metastasis","volume":"35","author":"Chaffer","year":"2016","journal-title":"Cancer Metastasis Rev."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s11684-018-0656-6","article-title":"Epithelial-to-mesenchymal transition in cancer: Complexity and opportunities","volume":"12","author":"Zhang","year":"2018","journal-title":"Front. Med."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Zheng, X., Yu, C., and Xu, M. (2021). Linking Tumor Microenvironment to Plasticity of Cancer Stem Cells: Mechanisms and Application in Cancer Therapy. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.678333"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s41568-021-00332-6","article-title":"Linking EMT programmes to normal and neoplastic epithelial stem cells","volume":"21","author":"Lambert","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/35000034","article-title":"The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells","volume":"2","author":"Batlle","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1242\/jcs.00224","article-title":"The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: A comparison with Snail and E47 repressors","volume":"116","author":"Bolos","year":"2003","journal-title":"J. Cell Sci."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1038\/sj.onc.1208429","article-title":"DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells","volume":"24","author":"Eger","year":"2005","journal-title":"Oncogene"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1158\/0008-5472.CAN-17-3139","article-title":"The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1","volume":"78","author":"Azad","year":"2018","journal-title":"Cancer Res."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Huang, X., Zhang, M., Pearce, A.D., Gibbons, M.D., Jin, D., Li, L., Hu, D., Liu, R., Yu, M., and Tan, M. (2025). Epithelial-Mesenchymal Transition Activates YAP to Drive Malignant Progression and Immune Evasion. Cancers, 17.","DOI":"10.20944\/preprints202507.1544.v1"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Thrash, H.L., and Pendergast, A.M. (2023). Multi-Functional Regulation by YAP\/TAZ Signaling Networks in Tumor Progression and Metastasis. Cancers, 15.","DOI":"10.3390\/cancers15194701"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"81062","DOI":"10.18632\/oncotarget.13188","article-title":"YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo","volume":"7","author":"Sun","year":"2016","journal-title":"Oncotarget"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"5719","DOI":"10.7150\/jca.99307","article-title":"High expression of ABL2 promotes gastric cancer cells migration, invasion and proliferation via the TGF-beta and YAP signaling pathways","volume":"15","author":"Liu","year":"2024","journal-title":"J. Cancer"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.3390\/curroncol29050247","article-title":"Immune Checkpoint Inhibitors in Cancer Therapy","volume":"29","author":"Shiravand","year":"2022","journal-title":"Curr. Oncol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1158\/1078-0432.CCR-15-1434","article-title":"Epithelial-Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma","volume":"22","author":"Lou","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1158\/0008-5472.CAN-16-3292","article-title":"Epithelial-to-Mesenchymal Transition Contributes to Immunosuppression in Breast Carcinomas","volume":"77","author":"Dongre","year":"2017","journal-title":"Cancer Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/cas.13237","article-title":"Programmed death-ligand 1 expression at tumor invasive front is associated with epithelial-mesenchymal transition and poor prognosis in esophageal squamous cell carcinoma","volume":"108","author":"Tsutsumi","year":"2017","journal-title":"Cancer Sci."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.1158\/0008-5472.CAN-16-0258","article-title":"Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma","volume":"76","author":"Clark","year":"2016","journal-title":"Cancer Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.21037\/tcr-22-292","article-title":"Bidirectional regulation between tumor cell-intrinsic PD-L1 and TGF-beta1 in epithelial-to-mesenchymal transition in melanoma","volume":"11","author":"Li","year":"2022","journal-title":"Transl. Cancer Res."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12943-015-0421-2","article-title":"Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: Significance in claudin-low breast cancer cells","volume":"14","author":"Alsuliman","year":"2015","journal-title":"Mol. Cancer"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.drup.2019.04.001","article-title":"YY1 regulates cancer cell immune resistance by modulating PD-L1 expression","volume":"43","author":"Hays","year":"2019","journal-title":"Drug Resist. Updat."},{"key":"ref_118","first-page":"e70181","article-title":"Bioinformatics Analysis of the Expression and Prognostic Significance of Transcription Factor YY1 in Gastric Cancer","volume":"8","author":"Chen","year":"2025","journal-title":"Cancer Rep."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Li, M., Wei, J., Xue, C., Zhou, X., Chen, S., Zheng, L., Duan, Y., Deng, H., Xiong, W., and Tang, F. (2023). Dissecting the roles and clinical potential of YY1 in the tumor microenvironment. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1122110"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Jo, H., Shim, K., and Jeoung, D. (2022). Potential of the miR-200 Family as a Target for Developing Anti-Cancer Therapeutics. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23115881"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.pharmthera.2015.01.011","article-title":"Prognostic significance of YY1 protein expression and mRNA levels by bioinformatics analysis in human cancers: A therapeutic target","volume":"150","author":"Bonavida","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"220186","DOI":"10.1098\/rsos.220186","article-title":"Bidirectional crosstalk between epithelial-mesenchymal plasticity and IFNgamma-induced PD-L1 expression promotes tumour progression","volume":"9","author":"Burger","year":"2022","journal-title":"R. Soc. Open Sci."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"29507","DOI":"10.18632\/oncotarget.8789","article-title":"Knockdown of CMTM3 promotes metastasis of gastric cancer via the STAT3\/Twist1\/EMT signaling pathway","volume":"7","author":"Yuan","year":"2016","journal-title":"Oncotarget"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3727\/096504016X14732523471442","article-title":"CKLF-Like MARVEL Transmembrane Domain-Containing Member 3 (CMTM3) Inhibits the Proliferation and Tumorigenisis in Hepatocellular Carcinoma Cells","volume":"25","author":"Li","year":"2017","journal-title":"Oncol. Res."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"528","DOI":"10.20892\/j.issn.2095-3941.2020.0032","article-title":"CMTM family proteins 1-8: Roles in cancer biological processes and potential clinical value","volume":"17","author":"Wu","year":"2020","journal-title":"Cancer Biol. Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1007\/s00262-022-03171-y","article-title":"CMTM6 as a master regulator of PD-L1","volume":"71","author":"Yaseen","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12935-020-01734-6","article-title":"Co-expression of CMTM6 and PD-L1: A novel prognostic indicator of gastric cancer","volume":"21","author":"Zhang","year":"2021","journal-title":"Cancer Cell Int."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1038\/onc.2017.47","article-title":"MUC1-C integrates PD-L1 induction with repression of immune effectors in non-small-cell lung cancer","volume":"36","author":"Bouillez","year":"2017","journal-title":"Oncogene"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Lems, C.M., Burger, G.A., and Beltman, J.B. (2023). Tumor-mediated immunosuppression and cytokine spreading affects the relation between EMT and PD-L1 status. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1219669"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Han, H., He, T., Wu, Y., He, T., and Zhou, W. (2024). Multidimensional analysis of tumor stem cells: From biological properties, metabolic adaptations to immune escape mechanisms. Front. Cell Dev. Biol., 12.","DOI":"10.3389\/fcell.2024.1441081"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10555-023-10141-y","article-title":"Epithelial-to-mesenchymal transition in cancer progression: Unraveling the immunosuppressive module driving therapy resistance","volume":"43","author":"Singh","year":"2024","journal-title":"Cancer Metastasis Rev."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/s41467-018-04313-6","article-title":"STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion","volume":"9","author":"Hsu","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2019.02.022","article-title":"PD-L1 promotes colorectal cancer stem cell expansion by activating HMGA1-dependent signaling pathways","volume":"450","author":"Wei","year":"2019","journal-title":"Cancer Lett."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Fortunato, O., Belisario, D.C., Compagno, M., Giovinazzo, F., Bracci, C., Pastorino, U., Horenstein, A., Malavasi, F., Ferracini, R., and Scala, S. (2020). CXCR4 Inhibition Counteracts Immunosuppressive Properties of Metastatic NSCLC Stem Cells. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.02168"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"123015","DOI":"10.1016\/j.lfs.2024.123015","article-title":"Cancer Stem Cell markers: Symphonic masters of chemoresistance and immune evasion","volume":"355","year":"2024","journal-title":"Life Sci."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13287-023-03241-7","article-title":"CD24+CD44+CD54+EpCAM+ gastric cancer stem cells predict tumor progression and metastasis: Clinical and experimental evidence","volume":"14","author":"Langley","year":"2023","journal-title":"Stem Cell Res. Ther."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev-pathol-020117-043854","article-title":"Epithelial Mesenchymal Transition in Tumor Metastasis","volume":"13","author":"Mittal","year":"2018","journal-title":"Annu. Rev. Pathol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1083\/jcb.201202014","article-title":"The evolving concept of cancer and metastasis stem cells","volume":"198","author":"Baccelli","year":"2012","journal-title":"J. Cell Biol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"e23171","DOI":"10.1016\/j.heliyon.2023.e23171","article-title":"Alternative immune checkpoints in immunoregulatory profile of cancer stem cells","volume":"9","author":"Mortezaee","year":"2023","journal-title":"Heliyon"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41392-024-01851-y","article-title":"Cancer stem cells: Advances in knowledge and implications for cancer therapy","volume":"9","author":"Chu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1038\/s41467-022-29930-0","article-title":"PD-L1 signaling selectively regulates T cell lymphatic transendothelial migration","volume":"13","author":"Piao","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"117247","DOI":"10.1016\/j.lfs.2019.117247","article-title":"Expression of programmed death ligand 1 (PD-L1) is associated with metastasis and differentiation in gastric cancer","volume":"242","author":"He","year":"2020","journal-title":"Life Sci."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.cell.2014.07.013","article-title":"Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis","volume":"158","author":"Aceto","year":"2014","journal-title":"Cell"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.ccell.2025.07.008","article-title":"Circulating tumor cells: Blood-based detection, molecular biology, and clinical applications","volume":"43","author":"Dai","year":"2025","journal-title":"Cancer Cell"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1038\/s41467-021-25189-z","article-title":"ICAM1 initiates CTC cluster formation and trans-endothelial migration in lung metastasis of breast cancer","volume":"12","author":"Taftaf","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1158\/2159-8290.CD-18-0065","article-title":"Homophilic CD44 Interactions Mediate Tumor Cell Aggregation and Polyclonal Metastasis in Patient-Derived Breast Cancer Models","volume":"9","author":"Liu","year":"2019","journal-title":"Cancer Discov."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.molonc.2015.05.009","article-title":"Frequent expression of PD-L1 on circulating breast cancer cells","volume":"9","author":"Mazel","year":"2015","journal-title":"Mol. Oncol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1038\/s41598-018-19245-w","article-title":"Evaluation of PD-L1 expression on vortex-isolated circulating tumor cells in metastatic lung cancer","volume":"8","author":"Dhar","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1002\/1878-0261.13675","article-title":"Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors\u2014A biomarker analysis of the ALICE and ICON trials","volume":"19","author":"Andresen","year":"2025","journal-title":"Mol. Oncol."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Schaller, J., and Agudo, J. (2020). Metastatic Colonization: Escaping Immune Surveillance. Cancers, 12.","DOI":"10.3390\/cancers12113385"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10585-021-10111-0","article-title":"Collective metastasis: Coordinating the multicellular voyage","volume":"38","author":"Wrenn","year":"2021","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"100825","DOI":"10.1016\/j.tranon.2020.100825","article-title":"Tumor-associated neutrophils suppress antitumor immunity of NK cells through the PD-L1\/PD-1 axis","volume":"13","author":"Sun","year":"2020","journal-title":"Transl. Oncol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"101866","DOI":"10.1016\/j.tranon.2023.101866","article-title":"Tumor associated neutrophils governs tumor progression through an IL-10\/STAT3\/PD-L1 feedback signaling loop in lung cancer","volume":"40","author":"Zhang","year":"2024","journal-title":"Transl. Oncol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13046-025-03375-x","article-title":"Natural killer cells: The immune frontline against circulating tumor cells","volume":"44","author":"Masmoudi","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s43018-020-0068-9","article-title":"Resistance to natural killer cell immunosurveillance confers a selective advantage to polyclonal metastasis","volume":"1","author":"Lo","year":"2020","journal-title":"Nat. Cancer"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/4\/1829\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T10:17:44Z","timestamp":1771237064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/4\/1829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,14]]},"references-count":155,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["ijms27041829"],"URL":"https:\/\/doi.org\/10.3390\/ijms27041829","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,14]]}}}